Proteoglycans (PG) are implicated in the atherosclerotic process through their capacity to bind and retain plasma low density lipoproteins (LDL) within the artery wall. As atherosclerosis progresses, arterial PG, particularly dermatan sulfate (DSPG) increase. Our preliminary data indicate that two distinct DSPG molecules (biglycan and decorin) are present in human aorta. The DSPG type which increases with atherosclerosis and the consequences of the increase are presently unknown. The goal of this proposal is to define the structure, metabolism and function of DSPG in the developing human atherosclerotic plaque. The hypothesis is that progression of atherosclerosis is associated with an alteration of smooth muscle cell metabolism resulting in a modulation in production of DSPG type. The modulation is critical in determining how fast atherosclerosis progresses. Production of arterial smooth muscle cell DSPG can be influenced by environmental factors (e.g. growth factors, presence of macrophages, cholesterol accumulations) as well as the intrinsic genetic potential of the cells. Using a comprehensive approach employing biochemical, histological, immunohistochemical, and electron microscopic techniques, properties of human aortic biglycan and decorin will be related to atherosclerotic changes or aging of the artery wall. Structural studies will include properties of core proteins and glycosaminoglycans (GAG). GAG size, chain substructure and content of iduronic acid will be examined since these properties influence potential binding to LDL. Metabolic studies in organ cultures will determine if increased DSPG results from increased synthesis or decreased turnover. A model system that mimics cell-cell interactions within the atherosclerotic plaque will be used to investigate modulations of DSPG in cultured human arterial smooth muscle cells exposed to macrophage conditioned media. Anticipated results of several studies include a stimulation of biglycan, increased binding capacity and affinity of biglycan to plasma LDL, and subsequent uptake of LDLPG by cultured macrophages, thus explaining a new mechanism whereby lipid loading of macrophages and development of atherosclerosis occurs. The ultimate implications include selective targeting to retard atherosclerosis development.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL025161-11
Application #
2215811
Study Section
Pathology A Study Section (PTHA)
Project Start
1979-12-01
Project End
1997-01-31
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Veterinary Sciences
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Shirk, R A; Parthasarathy, N; San Antonio, J D et al. (2000) Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J Biol Chem 275:18085-92
Schonherr, E; Zhao, B; Hausser, H et al. (2000) Lipoprotein lipase-mediated interactions of small proteoglycans and low-density lipoproteins. Eur J Cell Biol 79:689-96
Goldberg, I J; Wagner, W D; Pang, L et al. (1998) The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. J Biol Chem 273:35355-61
Geary, R L; Nikkari, S T; Wagner, W D et al. (1998) Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg 27:96-106;discussion 106-8
Parthasarathy, N; Goldberg, I J; Sivaram, P et al. (1996) Isolation of heparin-derived oligosaccharides containing 2-O-sulfated hexuronic acids, by lipoprotein lipase affinity chromatography. J Biochem Biophys Methods 32:27-32
Shirk, R A; Church, F C; Wagner, W D (1996) Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor II. Arterioscler Thromb Vasc Biol 16:1138-46
Edwards, I J; Xu, H; Obunike, J C et al. (1995) Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 15:400-9
McGee, M P; Teuschler, H; Parthasarathy, N et al. (1995) Specific regulation of procoagulant activity on monocytes. Intrinsic pathway inhibition by chondroitin 4,6-disulfate. J Biol Chem 270:26109-15
Edwards, I J; Xu, H; Wright, M J et al. (1994) Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thromb 14:1032-9
Manning, J M; Gebre, A K; Edwards, I J et al. (1994) Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans. Lipids 29:635-41

Showing the most recent 10 out of 25 publications